The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2019Transglutaminase 2 Inhibitors as a Disease-Modifying Treatment for Parkinson's Disease
Study Rationale:
Buildup and clumping of protein alpha-synuclein is a hallmark of Parkinson's disease (PD) and a likely cause of neurodegeneration and, ultimately, symptoms. It's important to know what... -
Alpha-Synuclein Biology and Therapies, 2019Alpha-synuclein-Binding Proteins on the Cell Surface as Novel Therapeutic Targets
Study Rationale:
Alpha-synuclein is a sticky protein that clumps in the brains of people with Parkinson's disease (PD). Recent research suggests that clumps of alpha-synuclein spreads in the brain... -
Research Grant, 2019New Activators of Parkin
Study Rationale:
Parkin is a protein made by all cells in the body, including brain cells. It plays an important role in the protection of neurons through a process known as quality control. Changes... -
Research Grant, 2019Imaging Techniques to Evaluate LRRK2 Activity in Idiopathic Parkinson's Disease
Study Rationale:
Inherited mutations in the LRRK2 gene are a common cause of Parkinson's disease that presents with clinical symptoms and brain changes similar to idiopathic (cause unknown) Parkinson... -
Research Grant, 2019Computer Simulation of LRRK2 and GBA Interactions to Identify Therapeutic Targets for Parkinson's Disease
Promising Outcomes of Original Grant:
Our original project aimed to create a computer simulation of biological pathways involved in Parkinson's disease and how genetic mutations in LRRK2 can change... -
Research Grant, 2019Developing an Alpha-synuclein Imaging Agent
Study Rationale:
The goal of this study is to develop an imaging tool (a radiotracer) that could be used to show the protein alpha-synuclein in the brains of living people with a brain scan call a...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.